Strengthening Global Investor Communication for a Biotech Company through Localization Translation Services

The Challenge: The Biotech Company’s Need to Strengthen Investor Communication

A biotech client recently approached MediTrans to address their challenge: effectively communicating news of their drug development progress and clinical trial findings to global investors.

The client recognized the urgent need for expert localization translation due to the following:

Complex Molecular Biology Topics: These concepts are intricate and require precision when translated.
Rapid Shifts in Scientific Trends: Trends in molecular biology evolve every 3 to 5 years, making up-to-date translations essential.
Timely Communication: Accurate and fast research and investment-related news delivery was critical to investor decision-making.

The Biotech Company’s Key Communication Challenges

The company faced the following three main challenges:

Reliable Translation:
Translating highly technical and scientific information into the target languages with complete accuracy.
Reflecting Latest Terminology:
Translating the latest, continuously evolving molecular biology terms and trends.
Speed & Efficiency:
Translating news and investor communications quickly to meet time-sensitive demands.

MediTrans’ Localization Translation Solution

To address these challenges, MediTrans delivered a tailored and expert-driven translation strategy with the following key elements:

Expert Team Composition

MediTrans assembled a team of translators with advanced degrees (Master’s or Doctorate) specializing in life sciences, biomedical sciences, and pharmaceutical research. This team can:

Monitor the latest research developments in real-time.
Grasp and translate complex molecular biology concepts accurately into target languages.
Customized Glossary Development

Working closely with the client, MediTrans developed a customized glossary tailored to the target market. This included:

Incorporating the latest scientific and industry terminology.
Defining unique terms related to specific research findings and products for clearer investor communication.
Rapid & Efficient Translation Workflow

MediTrans implemented real-time feedback loops and a cloud-based project management system to streamline translation processes. This system enabled:

Immediate communication with the client about progress.
A structured, responsive process capable of addressing urgent requests quickly.
Quality Assurance & Expert Review

Once translations were complete, MediTrans’ native-speaking subject matter experts conducted thorough reviews. These final quality checks ensured:

100% accuracy in a scientific context.
Alignment with local cultural nuances and conventions for effective communication.

The Results: Building Trust & Strengthening Investor Relationships

With MediTrans’ expert translation services, the client was able to:

✅ Build Trust with Global Investors:

The biotech company established credibility with its investor base through accurate and timely information.

✅ Receive Positive Investor Feedback:

Investors were equipped with the insights they needed to make informed decisions based on the latest research findings.

✅ Facilitate Additional Investment Opportunities:

Clear, accurate translations enabled investors to act with confidence, fostering new opportunities for strategic collaborations and funding.

Key Insights from This Case Study

Precision Builds Trust:
Accurate and contextually relevant translations foster credibility and confidence among global stakeholders.
Timely Communication Is Crucial:
Rapid response workflows enabled by MediTrans’ efficient systems ensured that urgent investor communications were met without delay.
Specialized Expertise Matters:
A team with domain-specific knowledge and scientific expertise made the difference in translating highly technical content.

MediTrans prioritizes confidentiality by signing an NDA with clients. This case is based on a real example, but the client name and project details have been changed.